160 related articles for article (PubMed ID: 35101425)
41. Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.
Ngo ATP; Jordan KR; Mueller PA; Hagen MW; Reitsma SE; Puy C; Revenko AS; Lorentz CU; Tucker EI; Cheng Q; Hinds MT; Fazio S; Monia BP; Gailani D; Gruber A; Tavori H; McCarty OJT
J Thromb Haemost; 2021 Apr; 19(4):1001-1017. PubMed ID: 33421301
[TBL] [Abstract][Full Text] [Related]
42. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO
Circulation; 2009 Aug; 120(5):417-26. PubMed ID: 19620499
[TBL] [Abstract][Full Text] [Related]
43. High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-/- mice.
Wilund KR; Yu L; Xu F; Hobbs HH; Cohen JC
J Lipid Res; 2004 Aug; 45(8):1429-36. PubMed ID: 15175362
[TBL] [Abstract][Full Text] [Related]
44. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
45. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
[TBL] [Abstract][Full Text] [Related]
46. An accelerated mouse model for atherosclerosis and adipose tissue inflammation.
Neuhofer A; Wernly B; Leitner L; Sarabi A; Sommer NG; Staffler G; Zeyda M; Stulnig TM
Cardiovasc Diabetol; 2014 Jan; 13():23. PubMed ID: 24438079
[TBL] [Abstract][Full Text] [Related]
47. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
[TBL] [Abstract][Full Text] [Related]
48. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
[TBL] [Abstract][Full Text] [Related]
49. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray.
Napoli C; de Nigris F; Welch JS; Calara FB; Stuart RO; Glass CK; Palinski W
Circulation; 2002 Mar; 105(11):1360-7. PubMed ID: 11901049
[TBL] [Abstract][Full Text] [Related]
50. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
Lian J; Quiroga AD; Li L; Lehner R
Circ Res; 2012 Sep; 111(8):982-90. PubMed ID: 22872154
[TBL] [Abstract][Full Text] [Related]
51. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
[TBL] [Abstract][Full Text] [Related]
52. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
53. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.
Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B
J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329
[TBL] [Abstract][Full Text] [Related]
54. Lipodystrophic gene Agpat2 deficiency aggravates hyperlipidemia and atherosclerosis in Ldlr
Peng K; Chen X; Pei K; Wang X; Ma X; Liang C; Dong Q; Liu Z; Han M; Liu G; Yang H; Zheng M; Liu G; Gao M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166850. PubMed ID: 37591406
[TBL] [Abstract][Full Text] [Related]
55. A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
Xu M; Wu X; Liu Z; Ding Y; Kong W; Little PJ; Xu S; Weng J
Biochem Biophys Res Commun; 2022 Sep; 622():163-169. PubMed ID: 35868060
[TBL] [Abstract][Full Text] [Related]
56. The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking.
Fedoseienko A; Wijers M; Wolters JC; Dekker D; Smit M; Huijkman N; Kloosterhuis N; Klug H; Schepers A; Willems van Dijk K; Levels JHM; Billadeau DD; Hofker MH; van Deursen J; Westerterp M; Burstein E; Kuivenhoven JA; van de Sluis B
Circ Res; 2018 Jun; 122(12):1648-1660. PubMed ID: 29545368
[TBL] [Abstract][Full Text] [Related]
57. Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish.
Liu C; Kim YS; Kim J; Pattison J; Kamaid A; Miller YI
J Lipid Res; 2018 Feb; 59(2):391-399. PubMed ID: 29187523
[TBL] [Abstract][Full Text] [Related]
58. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
59. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis.
Brandsma E; Kloosterhuis NJ; Koster M; Dekker DC; Gijbels MJJ; van der Velden S; Ríos-Morales M; van Faassen MJR; Loreti MG; de Bruin A; Fu J; Kuipers F; Bakker BM; Westerterp M; de Winther MPJ; Hofker MH; van de Sluis B; Koonen DPY
Circ Res; 2019 Jan; 124(1):94-100. PubMed ID: 30582442
[TBL] [Abstract][Full Text] [Related]
60. HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice.
Draijer R; Volger OL; Dahlmans VE; de Wit EC; Havekes LM; Princen HM
Biochem Pharmacol; 2002 May; 63(9):1755-61. PubMed ID: 12007578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
